The PharmaFluidics case – from start to exit

Wednesday, February 18, 11:00 - 12:15


Johan Devenyns | former CEO PharmaFluidics

Johan Devenyns has been active in the life sciences industry for over 20 years, as CEO of Peptisyntha, a peptide and oligonucleotide CDMO business, and CEO of PharmaFluidics, a pioneering proteomics research tools business - acquired by Thermo Fisher Scientific. 

He led a variety of fundraisings, M&A and successful exits. Currently, he is Chairman of LiveDrop Bio, a droplet biology instrument company, and advises life sciences ventures in various stages of creation & growth.

Johan holds a PhD in biomaterials, MBA and is a certified board director.

Powered by:
BCF Courses BV   

    Connect with us                  

Join BioBusiness Winter School
Privacy Policy
Terms & Conditions 
Chamber of Commerce: 75874415
         
  
  
  
      
Register 
© Copyright 2021 by BCF Courses